Following the sell-off, Lilly trades at a forward price-to-earnings (P/E) of 37 times 2025 analyst estimates, with a price-to ...

Zepbound is the preferred weight loss medicine vs. Wegovy and has consistently beaten the latter in U.S. weekly prescriptions ...

Eli Lilly and Company became the first tenant to move into Lebanon’s LEAP district during a groundbreaking ceremony on ...

A former Boone County bean field is where Lilly will research, develop, and manufacture the medicines of the future. Company ...

Officials from the Indianapolis-based drugmaker said the Lilly Medicine Foundry will help streamline the process of ...

Hims & Hers Health, Inc.'s Q1 results show 111% growth, yet shares fell 8%. Click for a look at the impact of drug access, ...

Baron Fifth Avenue Growth Fund declined during the first quarter of 2025, underperforming its benchmark, the Russell 1000 ...

President Donald Trump’s sweeping tariffs are headed to the medicine aisle next. On Monday, Trump announced his plans to ...

Palantir (PLTR) reported strong first-quarter results after the close on Monday, showcasing rapid growth across its U.S.

From a technical perspective, FTAI Aviation (FTAI) is looking like an interesting pick, as it just reached a key level of support. FTAI recently overtook the 20-day moving average, and this suggests a ...